MANNKIND CORP Contract with Customer, Liability, Noncurrent
MANNKIND CORP (MNKD) had Contract with Customer, Liability, Noncurrent of $36.86 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:ContractWithCustomerLiabilityNoncurrent · last filed 2026-08-05
- 2026-06-30: Contract with Customer, Liability, Noncurrent $36.86M.
- 2026-03-31: Contract with Customer, Liability, Noncurrent $38.91M.
- 2025-12-31: Contract with Customer, Liability, Noncurrent $39.98M.
- 2025-09-30: Contract with Customer, Liability, Noncurrent $48.19M.
| Period end | Contract with Customer, Liability, Noncurrent |
|---|---|
| 2026-06-30 | $36.86M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $38.91M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $39.98M 10-Q · filed 2026-08-05 |
| 2025-09-30 | $48.19M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $45.47M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $47.36M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $51.16M 10-K · filed 2026-02-26 |
| 2024-09-30 | $65.15M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $66.12M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $67.74M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $69.79M 10-K · filed 2025-02-26 |
| 2023-09-30 | $69.47M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $60.25M 10-Q · filed 2023-08-07 |
| 2023-03-31 | $45.66M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $37.68M 10-K · filed 2024-02-27 |
| 2022-09-30 | $32.00M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $29.76M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $26.12M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $19.54M 10-K · filed 2023-02-23 |
| 2021-09-30 | $1.55M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $1.59M 10-Q · filed 2021-08-11 |
| 2021-03-31 | $1.63M 10-Q · filed 2021-05-12 |
| 2020-12-31 | $1.66M 10-K · filed 2022-02-24 |
| 2020-09-30 | $1.70M 10-Q · filed 2020-11-04 |
| 2020-06-30 | $4.86M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $1.77M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $8.34M 10-K · filed 2021-02-25 |
| 2019-09-30 | $2.63M 10-Q · filed 2019-11-08 |
| 2019-06-30 | $8.40M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $15.87M 10-Q · filed 2019-05-07 |
| 2018-12-31 | $10.68M 10-K · filed 2020-02-25 |
| 2017-12-31 | $500.00K 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |